Analysis NetMed, Inc. (NTME)
5/30/2024
Analysis of NetMed, Inc. (NTME)
NetMed, Inc. (NTME) seems to be trading at a very low price of 0.00001. Looking at the technical indicators, the Relative Strength Index (RSI) is at 0.00000, indicating a neutral position. The Moving Average Convergence Divergence (MACD) is also at 0.00000, suggesting a lack of clear trend direction.In terms of moving averages, both the Simple Moving Average (SMA) and Exponential Moving Average (EMA) are at 0.00001, while the Weighted Moving Average (WMA) is also at 0.00001. This indicates that the stock price has been relatively stable recently.
Overall, based on the current data, it seems that NetMed, Inc. is not showing any significant price movements or clear trends. Further analysis and monitoring may be needed to make informed investment decisions regarding NTME.
Price target
The analysts' forecast for the future price of the security paper is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security paper, with the low end at $164, the high end at $250, and the average forecast at $202.26. The current price is below both the average and median forecast, indicating that there is potential for growth according to the analysts' predictions.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for the quarter ending on October 31, 2024, were not provided on time. However, on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows the stock's performance over the past year, including its beta, moving averages, and the range between its fifty-two-week low and high.
Valuation metrics reveal the company's price-to-earnings ratios, price-to-book ratio, and other key financial indicators. The market capitalization and enterprise value provide insights into the company's overall value in the market.
Lastly, dividends and splits information includes details about dividend rates, payout ratios, dividend yield, and historical split data. Key dates related to dividends and splits are also provided.
Income statement 💸
These are the revenues. Draw conclusions.Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been increasing over the years, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show a pattern of common stock repurchases, long-term debt issuances and payments, and dividend payments.
5. Investing activities include acquisitions, capital expenditures, and the sale and purchase of investments.
6. The end cash position has also been fluctuating, reaching its highest value in 2020.
7. Stock-based compensation has been a significant factor in the company's financial activities.
8. The company has been managing its cash flow effectively, with a focus on generating positive free cash flow and maintaining a healthy cash position.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a range from $1.27 to $1.36. This shows growth compared to the EPS of $1.26 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.53, with a range from $1.44 to $1.63. This indicates an increase from the EPS of $1.46 from the same quarter a year ago.
3. For the current year ending on September 30, 2024, the average EPS estimate is $6.59, with a range from $6.43 to $6.92. This reflects growth compared to the EPS of $6.13 from the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $7.23, with a range from $6.40 to $7.90. This suggests an increase from the EPS of $6.59 from the previous year.
Overall, the analysts' estimates show a positive outlook for the company's earnings per share, with expected growth in both the quarterly and annual results over the specified periods.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.5% in the current year.
- The growth rate is projected to increase to 5.6% in the current quarter and further to 4.8% in the next quarter.
- Over the next year, the growth rate is expected to reach 9.7%.
- Looking ahead, the company is forecasted to achieve an annual growth rate of 11% over the next 5 years.
- However, when compared to the past 5 years where the company experienced an annual growth rate of 20.15%, the future growth rate is expected to be lower.
MACD of NTME
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
